| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-09 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.23 | 5e-09 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.2 | 9e-09 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-08 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.28 | 7e-08 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-07 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-07 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.19 | 8e-07 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.18 | 9e-07 |